X
Logo de AEMPS
    • Castellano
    • Català
    • Euskera
    • Galego
    • Valencià
    • English
  • Inscripción en listas de distribución
  • LinkedIn AEMPS
  • Instagram AEMPS
  • YouTube AEMPS
  • X AEMPS
  • AEMPS
    • About Us
    • Public employment and scholarships
    • E-Office
    • AEMPS Procurement
    • I+D+i Projects
    • Information and assistance to citizens
    • Fees & Rates
    • COVID‑19
    • FAQs
    • Legislation
  • Medicines for human use
    • CIMA: Online Drug Information Center of the AEMPS
    • AEMPS Newsletters
    • Pharmacovigilance of medicines for human use
    • Therapeutic positioning reports
    • Research with medicines for human use
    • Medicines innovation and knowledge support office
    • Observatory on the use of medicines
    • European Union Arbitration
    • Medicine supply problems
    • Medicines in special situations
    • Non-substitutable medicines
    • Biological medicines
    • Narcotics and psychotropic substances
    • Illegal medicines
    • Legislation on medicines for human use
    • Homeopathics
    • Strategic medicines
    • Non-industrially manufactured drugs
    • Pharmacogenetics biomarkers
  • Veterinary medicines
    • CIMA Vet: AEMPS Online Information Center for Veterinary Medicines
    • AEMPS bulletin on veterinary medicines
    • Clinical research with veterinary medicines
    • Narcotics and psychotropics in veterinary medicine
    • Manufacture of drugs and active ingredients
    • Distance sales of veterinary medicines
    • Illegal veterinary medicines
    • Legislation on veterinary medicines
    • Pharmacovigilance of veterinary medicines
    • Prescription of veterinary medicines
    • Allergen-based medicines
  • Medical devices
    • Publications on medical devices
    • Medical devices
    • Marketing of medical devices in Spain
    • In vitro diagnostic medical devices
    • Clinical investigations with medical devices
    • Medical device surveillance
    • Registration of implantable medical devices
    • Notification of incidents involving medical devices
    • Legislation on medical devices
    • Breast implants
    • Guide for the pacemaker wearer
  • Cosmetics
    • Sanitary guarantees of cosmetic products
    • Cosmetics
    • Publications on cosmetics, biocides, AEMPS and personal care products
    • Legislation on cosmetic products
    • Cosmetovigilance
  • Biocides and personal care products
    • AEMPS Biocides
    • Personal care products
    • Legislation on biocides
    • Legislation on personal care products
    • Publications on cosmetics, biocides, AEMPS and personal care products
  • Press
    • AEMPS Information notes
    • AEMPS Publications
    • Institutional campaigns
    • Alerts
    • Scientific Articles
    • Events
    • Security Notes
    • AEMPS distribution lists
    • Training for researchers
  • Pharmaceutical Industry
    • Pharmaceutical laboratories: authorization, modification and registration
    • Medicines Registry
    • Inspection and Control
    • Active Ingredients: manufacturing, import and delivery
    • Labeling and Leaflets
    • Safety features of Medicines for Human Use
    • Human Pharmacovigilance: Pharmaceutical Industry
    • Commercialization of medicines
    • Fees & Rates
    • Industry and Delivery Regulation
    • Pharmaceutical delivery
    • Foreign trade
    • Allergen-based medicines
  • Healthcare Professionals
    • Pharmacies and hospital pharmacy services
    • Procedure for notification of drug movements: Pharmacies and pharmacy services
    • Medicine Supply Problems
    • Online legal sale of medicines for human use without prescription
    • Contact Points for foreign medicines in the Autonomous Regions
    • Notifications of Adverse Reactions
    • Non substituted medicines
    • Online sale of veterinary medicines
    • Pharmacopoeia and Master Formulation
    • Medicines Quality Issues
  • Citizens
    • CIMA: AEMPS Medicines for Human Use Online Information Center
    • Medicines subject of additional monitoring
    • Medicines and Driving
    • Medicine Supply Problems
    • AEMPS Publications
    • Informative brochures
    • Institutional campaigns
    • Ilegal Medicines
    • Information and assistance to citizens
    • Charter of services
    • Notifications of Adverse Reactions
    • Public participation in regulatory projects
    • Medicines and heat
  • CNCps
Inscripción en listas de distribución LinkedIn AEMPS Instagram AEMPS YouTube AEMPS X AEMPS
  • Castellano
  • Català
  • Euskera
  • Galego
  • Valencià
  • English
  • Inicio
  • Aviso legal
  • Mapa Web
  • Accesibilidad
  • Protección de datos
Inscripción en listas de distribución LinkedIn AEMPS Instagram AEMPS YouTube AEMPS X AEMPS
Isotipo AEMPS

Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
C/ Campezo nº 1, Edificio 8
28022, Madrid

Ministerio de Sanidad Sello Excelencia CAF